bsdmedical8k.htm


UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  February 6, 2014
 
BSD MEDICAL CORPORATION
 
(Exact name of registrant as specified in its charter)
 
Delaware
0-10783
75-1590407
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

2188 West 2200 South
 
Salt Lake City, Utah 84119
 
(Address of principal executive offices, including Zip Code)
 
Registrant’s telephone number, including area code:  (801) 972-5555
 
N/A
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
Item 5.07 Submission of Matters to a Vote of Security Holders.
 
On February 6, 2014, BSD Medical Corporation (the “Company”) held its 2014 Annual Meeting of Stockholders (“Annual Meeting”).  The matters voted on and the results of the votes were as follows:

1.  The stockholders elected seven members to the Board of Directors to serve until the next annual meeting or until their successors are duly elected and qualified.  The votes regarding this proposal were as follows:
 

   
Shares For
Withheld
Broker Non-Vote
 
Timothy C. McQuay
11,423,079
231,741
14,045,053
 
Harold R. Wolcott
11,499,106
155,714
14,045,053
 
Gerhard W. Sennewald
11,510,733
144,087
14,045,053
 
Michael Nobel
11,423,879
230,941
14,045,053
 
Douglas P. Boyd
11,429,779
225,041
14,045,053
 
Steven G. Stewart
11,426,876
227,944
14,045,053
 
Damian E. Dupuy
 
 
11,511,206
143,614
14,045,053

 
2.  The stockholders ratified the selection of Tanner LLC as the Company’s independent registered public accountants for the fiscal year ending August 31, 2014.  The votes regarding this proposal were as follows:
 
Shares For
Shares Against
Abstain
23,078,642
254,308
2,366,923
     

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
BSD MEDICAL CORPORATION
 
Date:  February 7, 2014
 
By:  /s/ William S. Barth                                                                
Name:  William S. Barth
Title:    Chief Financial Officer